At SCOPE Summit, Craig Lipset shared a blunt assessment of clinical trial innovation: the tools exist, regulators are engaged, and digital approaches offer clear quality advantages — yet adoption remains the industry’s biggest hurdle. From evolving FDA inspection expectations to the normalization (and lingering misconceptions) of decentralized trials, Lipset argues progress will depend less on new technology and more on scaling what already works.
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
ON-DEMAND WEBINARS
Join leading clinical experts as they debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter decisions.
The DECODE Obesity initiative aims to advance obesity drug development by generating evidence and optimizing digital health technologies to assess treatment benefits beyond weight loss.
This presentation explores how digital health technologies are transforming the way persistent cough is monitored and understood across various respiratory diseases.
Discover how maintaining strong data integrity can transform your clinical trials and strategies you can use to optimize trial builds and streamline data collection processes, ultimately leading to faster approvals.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1342154721 doctors]( "Why Your eTMF Needs Role-Based Access")
Why Your eTMF Needs Role-Based AccessDiscover how role-based access controls can offer a way for clinical teams to answer the tough questions from regulators, investors, and other parties.
-
![GettyImages-1026593952 tablet, data]( "Driving Enrollment Predictability In Clinical Trial Timelines")
Driving Enrollment Predictability In Clinical Trial TimelinesMissed enrollment targets cost millions—TA Scan’s benchmarking and simulation tools empower sponsors to forecast with confidence, optimize site strategy, and keep budgets on track.
-
![GettyImages-1363170016 wearables]( "The Future Of eCOA & Wearable Devices")
The Future Of eCOA & Wearable DevicesLearn how by looking at the advantages of wearables and where they are headed in the future, manufacturers, providers, and researchers can better anticipate collaboration efforts to bridge the gaps in existing processes and maximize the potential of eCOA wearables in clinical research.
-
![GettyImages-1391107088 patient experience]( "Medable Platform Delivers >90% eCOA Adherence And Scalability")
Medable Platform Delivers >90% eCOA Adherence And ScalabilityDiscover how eCOA use drove >90% adherence across an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites.
-
![GettyImages-1923661781-asian-japanese-laptop-business]( "Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence")
Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA AdherenceA top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.
-
![GettyImages-1468678613-doctor-setting-ipad-badge-hand]( "Sustainable Clinical Trials Through eClinical Innovation")
Sustainable Clinical Trials Through eClinical InnovationClinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
-
![Risk Management-GettyImages-665231256]( "Flexible Integrations To Reduce Risks And Increase Efficiencies")
Flexible Integrations To Reduce Risks And Increase EfficienciesLearn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
![Risk GettyImages-175454347]( "Implementing ICH E6 (R3) In A Risk Averse Culture")
Implementing ICH E6 (R3) In A Risk Averse CultureGet several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.
-
![Depression-gettyimages-1309050890]( "Improving Patient Outcomes With Wearables In Major Depressive Disorder")
Improving Patient Outcomes With Wearables In Major Depressive DisorderLearn how medical-grade wearable devices can help advance treatments in conditions like major depressive disorder and paint a more complete picture of patients with this often debilitating condition.
-
![AI helping in health care-GettyImages-2162977830]( "The Future Of AI In Clinical Research, Delivered Today")
The Future Of AI In Clinical Research, Delivered TodayThe FDA's new guidance outlines a future where AI models support regulatory submissions, taking a pivotal step toward modernizing regulatory science.
FROM THE EDITOR
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
- The Dream Is EHR-To-EDC — eSource Is The Wake-Up Call
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i